Fundraising Fox
Syngoi
AcquiredWatertown, US · 3 known investors
Find your way into Syngoi
Sign up to see every warm intro you have to Syngoi
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Syngoi team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Artis BioSolutions is an integrated platform for genetic medicine that produces enzymatically synthesized synthetic DNA and develops it into clinical-grade advanced therapies with in-house GMP manufacturing. It serves developers of advanced therapy medicinal products across modalities such as mRNA, gene editing, viral vectors, cell therapies, and vaccines, with production sites in Watertown, MA (US) and Bilbao, Spain (EU).
Investors · 3
How we know: Asahi Kasei Corporate Venture Capital's portfolio page · Not right? Tell us
How we know: Buenavista Equity Partners's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Syngoi do?
- Artis BioSolutions is an integrated platform for genetic medicine that produces enzymatically synthesized synthetic DNA and develops it into clinical-grade advanced therapies with in-house GMP manufacturing. It serves developers of advanced therapy medicinal products across modalities such as mRNA, gene editing, viral vectors, cell therapies, and vaccines, with production sites in Watertown, MA (US) and Bilbao, Spain (EU).
- Who are Syngoi's investors?
- Syngoi's investors include Asahi Kasei Corporate Venture Capital, Buenavista Equity Partners, Columbus Venture Partners.
- Where is Syngoi headquartered?
- Syngoi is headquartered in Watertown, US.